Sec Form 13G Filing - AFP Integra S.A. filing for AUNA S.A. (AUNA) - 2024-12-18

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
SCHEDULE 13G 0002046651 XXXXXXXX LIVE Class A Ordinary Shares, nominal value US$0.01 per share (the "Class A Shares") 03/27/2024 0001799207 Auna S.A. L0415A103 46A, Avenue J.F. Kennedy, Grand Duchy of Luxembourg N4 L-1855 Rule 13d-1(b) AFP Integra S.A. acting on behalf of IN-Fondo 1, IN-Fondo 2 and IN-Fondo 3 R5 0.00 9013333.00 0.00 9013333.00 9013333.00 N 30.04 FI Auna S.A. 46A, Avenue J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg AFP Integra S.A. acting on behalf of IN-Fondo 1, IN-Fondo 2 and IN-Fondo 3 Av. Canaval y Moreyra 522, piso 5 y 6, San Isidro, Lima - Peru Peru N FI non-US pension fund. As of March 27, 2024, IN-Fondo 1, IN-Fondo 2 and IN-Fondo 3 owned 9,013,333 shares of the Issuer's Class A Shares. As of March 27, 2024 the Reporting Persons may be deemed to have beneficially owned 9,013,333 shares of the Issuer's Class A Shares or 30.04% of Class A Shares outstanding. This percentage is based on 30,000,000 Class A Shares outstanding as of March 27, 2024 as reported by the Issuer in the Final Prospectus. 0 9,013,333 0 9,013,333 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to IN-Fondo 1, IN-Fondo 2 and IN-Fondo 3 is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to IN-Fondo 1, IN-Fondo 2 and IN-Fondo 3 is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D AFP Integra S.A. acting on behalf of IN-Fondo 1, IN-Fondo 2 and IN-Fondo 3 /s/ Daphne Elizabeth Zagal Otiniano 12/18/2024